SCHEMBL23328720

SCHEMBL23328720

COP(=O)(O)CNC(=S)Nc1ccc(C(F)(F)F)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.55
MEN1 O00255 6/20 0.54
KMT2A Q03164 6/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
LMNA P02545 4/20 0.54
HTT P42858 3/20 0.54
ALDH1A1 P00352 2/20 0.51
MAPT P10636 2/20 0.51
GAA P10253 1/20 0.51
FPR2 P25090 1/20 0.46
EPHX2 P34913 1/20 0.43
TRPV1 Q8NER1 1/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
GMNN O75496 1/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
HTR1A P08908 1/20 0.42
THRB P10828 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23328371 0.87 CDK1 (0.59) CDK1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL25841022 0.85 FPR2 (0.49) MEN1KMT2ASMN1; SMN2LMNAHTT
SCHEMBL25841011 0.85 MEN1 (0.58) MEN1KMT2ASMN1; SMN2LMNAHTT
SCHEMBL23328875 0.85 KMT2A (0.63) CDK1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL23328399 0.85 CDK1 (0.61) CDK1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL23328372 0.77 CDK1 (0.67) CDK1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL23328673 0.75 MEN1 (0.63) MEN1KMT2AFPR2EPHX2TRPV1
SCHEMBL14386106 0.75 LMNA (0.72) CDK1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL23328449 0.75 MEN1 (0.67) CDK1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL23328722 0.74 MEN1 (0.61) MEN1KMT2ASMN1; SMN2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11701333-B2 Antibacterial compounds Kent Innovation & Enterprise (GB) 2023-07-18 US disclosed
US-20210128501-A1 ANTIBACTERIAL COMPOUNDS KENT INNOVATION & ENTERPRISE, UNIVERSITY OF KENT (GB) 2021-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11701333-B2 Antibacterial compounds ARF1, ARL1, TLR1 CDK1 1597/4885MEN1 1300/4885KMT2A 2533/4885
US-20210128501-A1 ANTIBACTERIAL COMPOUNDS ARF1, ARL1, TLR1 CDK1 1597/4885MEN1 1300/4885KMT2A 2533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.